Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions

Eur Cytokine Netw. 2004 Jul-Sep;15(3):210-6.

Abstract

Psoriasis is a T cell-mediated inflammatory skin disease characterized by an elevated IFN-gamma and IL-12p70 expression in skin lesions. Interleukin-18 (IL-18) synergizes with IL-12 to induce IFN-gamma production and a strong T-helper-1-mediated immune response, or to induce Th2 polarization depending on the immunological context. We have previously shown that keratinocytes in normal skin produce and store large amounts of pro-IL-18. In this study, we hypothesized that the expression of IL-18 in psoriatic lesional skin might be altered compared to normal skin. Therefore, IL-18 expression was assessed in psoriatic, stable, plaque-type lesions and early active and progressive lesions. IL-18 mRNA and protein concentrations were constitutively high, and did not differ between normal and stable, plaque-type epidermis. In active and progressive lesions an elevated expression of total IL-18 protein relative to normal and stable, plaque-type epidermis was detected using ELISA, while on Western blot, the differences in pro- or mature IL-18 were less clear. Our results indicate that the role of IL-18 in the pathogenesis of early phases of psoriasis may be more prominent than in established psoriatic lesions.

MeSH terms

  • Blotting, Western
  • DNA Primers
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunohistochemistry
  • Interleukin-18 / genetics
  • Interleukin-18 / metabolism*
  • Psoriasis / immunology
  • Psoriasis / metabolism*
  • Psoriasis / pathology
  • RNA, Messenger / genetics
  • Skin / metabolism

Substances

  • DNA Primers
  • Interleukin-18
  • RNA, Messenger